Human adrenal aging presents a stark divergence between the zona fasciculata (ZF) and the zona reticularis (ZR). While cortisol production stays robust or even increases with age—maintaining the body’s catabolic mobilization of energy—DHEA levels plumment by as much as 90% [pmc.ncbi.nlm.nih.gov/articles/PMC3746247/]. This 'adrenopause' isn't just a random failure of the ZR; it looks like a programmed metabolic triage. The body seems to sacrifice the high-entropy, inefficient neural signaling supported by DHEA in favor of the low-entropy, survival-oriented efficiency of cortisol.

DHEA as a Neurometabolic Noise Generator

Recent frameworks suggest that high-order cognition emerges from 'neurometabolic entanglement,' where the brain operates in a metabolically expensive, far-from-equilibrium state to maintain complex, noise-rich signaling [frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2023.976036/full]. DHEA and its sulfate (DHEAS) are potent neurosteroids that tune this neural stochasticity by modulating GABAA and NMDA receptors. While cortisol enforces a narrow state focused on metabolic priorities, DHEA promotes synaptic plasticity and helps shield the hippocampus from glucocorticoid-induced atrophy [pmc.ncbi.nlm.nih.gov/articles/PMC6374303/].

The ZR likely serves as a systemic 'entropy reservoir.' By maintaining high circulating DHEA, the adrenal cortex provides the central nervous system with the substrate needed to sustain high-dimensional cognitive states that are, by their nature, inefficient. As cardiovascular and metabolic overhead increases with age, the cost of maintaining this noise becomes unsustainable. The HPA axis then shifts toward a state of 'functional simplification.'

Zonal Rarefaction as Metabolic Triage

Building on the idea of centripetal microvascular rarefaction, the 'watershed' ischemia in the ZR acts as the physical mechanism for this triage. Because the ZR sits at the end of the adrenal microcirculatory flow, it's the first to suffer when oxygen and nutrients are limited. In a state of systemic decline, the body prioritizes the 'efficient' ZF—which ensures immediate survival via glucose mobilization—over the 'inefficient' ZR, which supports the expensive signaling required for cognitive flexibility and subjective experience.

This explains why DHEA decline correlates so strongly with cognitive decline and hippocampal volume loss [pmc.ncbi.nlm.nih.gov/articles/PMC6374303/]. We aren't just losing a hormone; we're losing the metabolic 'slack' that allows the brain to be more than a simple input-output machine. The loss of the ZR marks the transition from an 'inhabited' brain (high-entropy, DHEA-supported) to an 'optimized' brain (low-entropy, cortisol-dominant).

Predictions and Falsifiability

If this hypothesis holds, we should see the following:

1. Entropy Mapping: fMRI studies using multiscale entropy (MSE) analysis should show a direct correlation between DHEA:Cortisol ratios and the complexity of the Default Mode Network, independent of absolute glucose metabolic rates.
2. Thermodynamic Cost: DHEA supplementation in older individuals should increase the brain's 'metabolic waste' (such as higher heat production or disproportionate oxygen consumption) relative to task performance. This would reflect a shift back toward 'inefficient' consciousness-sustaining states.
3. Failure of Efficiency: Pharmacological attempts to optimize neural efficiency (e.g., via specific GABA-agonists) might preserve 'processing speed' but will fail to improve subjective measures of 'presence' or complex problem-solving because they bypass the need for DHEA-induced noise.

This framework challenges the view of DHEA as a 'failed' supplement [mayoclinic.org/drugs-supplements-dhea/art-20364199]. If DHEA's role is to support 'inefficiency,' then judging it by 'efficiency metrics' like speed or accuracy is a mistake. We should instead look for its effects on the high-dimensional noise that makes human cognition unique.